These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8151542)

  • 1. [Lymphoproliferative lesions localized in the renal graft. A French multicenter study].
    Renoult E; Kessler M
    J Radiol; 1994 Jan; 75(1):53-6. PubMed ID: 8151542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    Transplantation; 2004 Feb; 77(3):431-7. PubMed ID: 14966421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma of the native kidney in patients with renal transplantation. A French multicenter study].
    Renoult E; Kessler M
    J Radiol; 1994 Jan; 75(1):49-52. PubMed ID: 8151540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
    Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
    Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders and hematologic malignancies following organ transplantation.
    Ferry JA; Jacobson JO; Conti D; Delmonico F; Harris NL
    Mod Pathol; 1989 Nov; 2(6):583-92. PubMed ID: 2587566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
    Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
    Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus-associated posttransplant lymphoproliferative disease after renal transplantation].
    Matsubara E; Yakushijin Y; Nomura T; Iwamasa K; Narumi H; Sakai I; Yasukawa M; Fujita S; Hato T; Ohshima K; Uno M
    Rinsho Ketsueki; 2002 Oct; 43(10):949-53. PubMed ID: 12462032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of malignant neoplasms in cardiac transplant recipients uniformly treated with prophylactic antilymphocyte globulin.
    Dresdale AR; Lutz S; Drost C; Levine TB; Fenn N; Paone G; del Busto R; Silverman NA
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1202-7. PubMed ID: 8246561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S; Lachat V; Moulin B
    Transpl Int; 2000; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.